Vaccine Candidate Effective Against Multiple Fungal Infections
People with diabetes, COPD, or co-infections such as COVID-19, tuberculosis or flu, are at higher risk of developing fungal infections.
People with diabetes, COPD, or co-infections such as COVID-19, tuberculosis or flu, are at higher risk of developing fungal infections.
Treatment with tezepelumab (Tezspire) can substantially reduce or eliminate oral corticosteroid (OCS) use in adults with OCS-dependent severe asthma, according to new Phase 3 WAYFINDER results presented at ATS 2025.
Infants with more severe bronchopulmonary dysplasia showed signs of ciliary dysfunction that were not present in those with moderate disease.
Study suggests the 2024 withdrawal of the asthma medication Flovent was linked to increases in children discontinuing inhaled steroid therapy.
Higher levels of perceived stress—or how overwhelmed or stressed a person feels based on their personal understanding of their condition—can have physiological impacts on a COPD patient's disease symptoms.
Changes in lung function are of critical importance to patients with cystic fibrosis (CF), as lung function is a key indicator of disease progression and treatment effectiveness.
An FDA-approved cancer drug may help the immune system clear out damaged cells that cause the lung scarring, potentially restoring lung function in patients with pulmonary fibrosis.
A small population of immune cells in the intestine prevented allergic responses to food, suggesting that targeting such cells therapeutically could potentially lead to a new treatment for allergies.
Brensocatib significantly reduced the rate of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis compared to placebo.